On January 8, 2021 CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, reported that Geert Kersten, Chief Executive Officer, is scheduled to present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference, being held on January 11-14, 2021 (Press release, Cel-Sci, JAN 8, 2021, View Source [SID1234573717]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The presentation will be available for on-demand listening beginning January 11, 2021 at 6:00 AM Eastern Time. Interested parties may access the recorded webcast of this presentation at View Source or on CEL-SCI’s website at View Source, where it will be available for 90 days following the conclusion of the event.